National Academies Press: OpenBook
« Previous: Appendix B: Workshop Task and Agenda
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

Appendix C

Biographies of Speakers and Planning Committee Members

PLANNING COMMITTEE BIOGRAPHIES

Eli Y. Adashi, M.D., is a professor of medical science at Brown University. He served as the fifth dean of medicine and biological sciences at Brown, John A. Dixon Endowed Presidential Professor and Chair in the Department of Obstetrics and Gynecology at the University of Utah Health Sciences Center, and director of the Division of Reproductive Endocrinology at the University of Maryland. Dr. Adashi, an academic physician-executive, is a graduate of the Tel Aviv University School of Medicine and the Harvard T.H. Chan School of Public Health program in health care management. He did his residency in obstetrics and gynecology at Tufts and fellowship and postdoctoral training in reproductive endocrinology at Johns Hopkins and University of California, San Diego (UCSD). Dr. Adashi received continuous NIH funding (1985–2005) in the general area of reproduction and is a practicing clinical reproductive endocrinologist. He is a member or fellow of the National Academy of Medicine (NAM), Association of American Physicians (AAP), American Association for the Advancement of Science (AAAS), and Hastings Ethics Center. His honors include Doctor Honoris Causa: Poznan University of Medical Sciences and University of Ottawa and Distinguished Medical Alumnus, Johns Hopkins University School of Medicine. He is president of the Societies of Reproductive Investigation and Reproductive Endocrinology and an examiner and director of the Division of Reproductive Endocrinology of the American Board of Obstetrics and Gynecology. Elected to NAM in 1999, Dr. Adashi has served on multiple consensus

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

committees, as review coordinator for 25 NAM reports, and as chair of the Maternal and Child Health and Human Development interest group.

Amander Clark, Ph.D., is a professor of molecular cell and developmental biology and director of the Center of Reproductive Science, Health, and Education at the University of California, Los Angeles (UCLA). Dr. Clark is a stem cell scientist, geneticist, and developmental biologist and internationally recognized for her work on the germline and in vitro gametogenesis. She has authored over 100 research articles and is regularly invited to speak on the use of stem cells to understand fertility and infertility. Dr. Clark’s research is supported by grants from NIH, Bill and Melinda Gates Foundation, California Institute of Regenerative Medicine, Templeton Foundation, and LucaBella Foundation. Her work has been recognized by awards from the International Society for Stem Cell Research (ISSCR), STOP Cancer, Lance Armstrong Foundation, and Concern Foundation and lectureships from national and international scientific and medical societies. She is the inaugural director of the UCLA Center for Reproductive Science, Health, and Education and president-elect of the ISSCR, a global nonprofit that promotes excellence in stem cell science and applications to human health.

I. Glenn Cohen, J.D., is deputy dean and James A. Attwood and Leslie Williams Professor of Law, Harvard Law School and faculty director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. He is an internationally recognized expert on health law and the intersection of bioethics (sometimes called “medical ethics”) and the law. His current projects relate to big data, health information technologies, mobile health, reproduction/reproductive technology, research ethics, organ transplantation, rationing in law and medicine, health policy, Food and Drug Administration (FDA) law, translational medicine, and medical tourism. He authored more than 200 articles and chapters and is the author, coauthor, editor, or coeditor of more than 18 books. His work has appeared in or been covered in venues such as PBS, NPR, ABC, CNN, MSNBC, Mother Jones, New York Times, and New Republic. He served as a law clerk to Judge Michael Boudin of the U.S. Court of Appeals for the First Circuit and as a lawyer for the U.S. Department of Justice, Civil Division, Appellate Staff, where he handled litigation in the Courts of Appeals and (in conjunction with the Solicitor General’s Office) in the Supreme Court. He was selected as a Radcliffe Institute Fellow for 2012–2013 and by the Greenwall Foundation to receive a Faculty Scholar Award in Bioethics.

Susan Crockin, J.D., is head of the Crockin Law & Policy Group, one of the first U.S. firms devoted exclusively to the intertwined legal aspects

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

of assisted reproductive technologies (ART) and adoption. She is also a faculty affiliate and O’Neill Institute Legal Scholar at Georgetown University Law Center and an adjunct professor at Eastern Virginia Medical School. Ms. Crockin has devoted her legal career to the emerging issues surrounding ART, particularly the impact of scientific and medical advances on existing tenets of family, health, and reproductive law. Her current work focuses on the legal implications of cryopreservation and disposition of patient and donor gametes and embryos; reproductive genetics; egg and sperm banking; equitable use and third-party coverage of fertility and reproductive genetic treatments for those whose family-building ability depends on them; interprofessional efforts to reduce health care costs related to fertility treatments through single-embryo transfer, insurance, and other methods; and cross-border reproductive care, including international surrogacy. In addition to being a frequent speaker on ART law–related topics, Ms. Crockin has published three books, numerous chapters and peer-reviewed articles, and, since 1990, a national legal column that she created, “Legally Speaking.” She helped draft the Massachusetts infertility mandate, the American Bar Association’s initial Model ART Act, and continues to draft and revise model in vitro fertilization (IVF) consent forms for the Society of Assisted Reproductive Technology (SART). She is a founding member of the American Academy of Reproductive Technology Attorneys, where she chaired its committee to update its code of ethics, and is working on efforts to develop a national donor gamete registry affiliated with SART. Ms. Crockin received her J.D. from Northeastern University School of Law and her B.A. from Tufts University, summa cum laude.

Ubaka Ogbogu, L.L.M., S.J.D., is a professor and associate dean (research) in the Faculty of Law at the University of Alberta. He is a member of the Royal Society of Canada’s College of New Scholars, Artists and Scientists (2023 Cohort), Katz Group Chair in Health Law and chair of the University of Alberta Research Ethics Board 2. Dr. Ogbogu is a recipient of the Confederation of Alberta Faculty Associations Distinguished Academic Early Career Award. He holds a doctorate in law from the University of Toronto, a Master of Laws degree from the University of Alberta and undergraduate degrees in law from the University of Benin, Nigeria, and the Nigerian Law School. Ogbogu’s scholarly work is focused broadly on the ethical, legal, and societal implications of novel and emerging biotechnologies and associated research. His publications have explored a diverse range of issues in this field, including the ethical and legal issues associated with stem cell research, gene and engineered cell therapies, biobanks, germline gene editing and assisted reproductive technologies. As a multidisciplinary scholar, his teaching and research activities explore

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

and cut across various fields, including health law, bioethics, science policy, science and technology studies, public health, legal history, and legal philosophy. He has led or been involved in many prominent national and international biotechnology policy-making activities and writes and comments frequently in the popular press on matters relating to the impacts of biotechnology and science on society. Ogbogu has served on numerous boards and councils, including the Health Quality Council of Alberta, Council of Canadian Academies Expert Panel on Somatic Gene and Engineered Cell Therapies, the Council of Canadian Academies Expert Panel on Medical Assistance in Dying, the Canadian Institutes of Health Research (CIHR) Stem Cell Oversight Committee, the Canadian Institutes of Health Research Governing Council’s Standing Committee on Ethics, and the International Society for Stem Cell Research Task Force on Guidelines for Stem Cell Research and Clinical Translation.

Kotaro Sasaki, M.D., Ph.D., is an assistant professor at the University of Pennsylvania School of Veterinary Medicine. His major research interest involves understanding the molecular mechanisms of human germ cell and gonadal development using single-cell genomics and their in vitro reconstitution using pluripotent stem cells (PSCs). He is a board-certified anatomic pathologist and completed anatomic pathology residency at the University of Pittsburgh in 2011 and renal pathology fellowship at the University of Washington in 2012. Before the University of Pennsylvania, he completed a postdoc training at Mitinori Saitou Lab at Kyoto University, Japan.

Melissa Simon, M.D., M.P.H., is the George H. Gardner Professor of Clinical Gynecology and professor of obstetrics and gynecology, preventive medicine, and medical social sciences at Northwestern University Feinberg School of Medicine. She serves as vice chair of research in the Department of Obstetrics and Gynecology and director of the Institute for Public Health and Medicine in the Center for Health Equity Transformation. Dr. Simon’s primary research interests are aimed at promoting health equity and eliminating health disparities among low-income, medically underserved women across the life span. Integrating health services research with social epidemiologic models, Dr. Simon focuses on interventions that aim to reduce and eliminate such disparities. She prefers to leverage culture and community to achieve these goals and integrates a community-based participatory research framework into her work. She also has a strong portfolio of workforce development programs, including the world’s first health care pipeline development free massive open online course, “Career 911: Your Future Job in Medicine and Healthcare” on the Coursera platform. She is the founding director of the

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

Center for Health Equity Transformation and the Chicago Cancer Health Equity Collaborative and a former member of the U.S. Preventive Services Task Force. Dr. Simon is a member of NAM, AAP, the NAM Board on Population Health and Public Health Practice, and the Roundtable for the Promotion of Health Equity. She also serves as an advisory committee member to the NIH Office of Research on Women’s Health.

Hugh S. Taylor, M.D., is the Anita O’Keeffe Young Professor of Women’s Health and chair of the Department of Obstetrics, Gynecology, and Reproductive Science at Yale University School of Medicine and a professor of molecular, cellular, and developmental biology at Yale. He is a board-certified specialist in obstetrics/gynecology and reproductive endocrinology. Dr. Taylor received his undergraduate training at Yale and his medical degree from the University of Connecticut School of Medicine. At Yale, he completed his residency in obstetrics and gynecology and postdoctoral fellowships in reproductive endocrinology and infertility and molecular biology. Dr. Taylor has been principal investigator (PI) on 15 NIH grants and site PI or coinvestigator on numerous additional NIH-funded projects. His clinical research centers on implantation, endometriosis, and menopause. His basic science research focuses on uterine development, the regulation of developmental gene expression by sex steroids, endocrine disruption, and stem cells. Dr. Taylor has published more than 400 articles in leading medical journals and is an author of Speroff’s Clinical Gynecologic Endocrinology and Infertility. He serves on several editorial boards and as a reviewer for numerous scientific journals and is frequently invited as a speaker at national and international medical meetings. Dr. Taylor has received awards that include the IVI Foundation International Award for the Best Research in Reproductive Medicine and the Society for Gynecologic Investigation Distinguished Scientist Award. He is past president of the Society for Reproductive Investigation and immediate past president of the American Society for Reproductive Medicine. He was elected to NAM in 2016.

SPEAKER BIOGRAPHIES

Paula Amato, M.D., is professor of obstetrics and gynecology and director of the Division of Reproductive Endocrinology and Infertility at Oregon Health and Science University. Dr. Amato received her M.D. from the University of Toronto in Canada, where she also completed her residency in obstetrics and gynecology, followed by a fellowship in reproductive endocrinology and infertility at UCSD. Dr. Amato is president-elect of the American Society for Reproductive Medicine. Her research focuses on innovative ART to treat age-related infertility.

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

Andrea Braverman, Ph.D., M.S., M.A., is a clinical professor with a joint appointment in the Department of Obstetrics and Gynecology and Psychiatry and Behavioral Medicine at Thomas Jefferson University and the associate director for the Educational Core for OBGYN. She is a health psychologist with a specialty in medical health management, infertility counseling, and third-party reproduction issues. She received her M.A., M.S., and Ph.D. in psychology from the University of Pennsylvania. Dr. Braverman has lectured internationally on treatment issues and reproductive medicine before medical and patient audiences. She has published in medical journals about the psychological aspects of infertility, issues involved in the decision to end treatment, and psychological issues related to using third-party donors. Dr. Braverman received the Timothy Jeffries Memorial award in 2011 for outstanding contributions as a health psychologist from the American Psychological Association. She is a board member of RESOLVE.

Ali Brivanlou, Ph.D., is the Robert and Harriet Heilbrunn Professor at Rockefeller University. He uses in vitro attached human embryos and genome-edited “synthetic embryos” derived from human embryonic stem cells to unveil the molecular, cellular, and embryological basis of early human development. His studies employ high-resolution quantitative approaches and span both theoretical physics and molecular embryology. The Brivanlou laboratory is particularly interested in the emergence of the human brain and modeling neurodegenerative diseases; it has helped establish a groundbreaking system to study the molecular and cellular processes during implantation (a critical stage, when the forming embryo attaches to the uterus) that vastly expands scientists’ ability to answer basic questions about human development and understand early pregnancy loss. Dr. Brivanlou received his Ph.D. in molecular biology from the University of California, Berkeley.

Alana Cattapan, Ph.D., M.A., is the Canada Research Chair in the Politics of Reproduction and an assistant professor in the Department of Political Science at the University of Waterloo. She studies gendered inclusion in policy making, identifying links between the state, the commercialization of the body, and reproductive labor. She has published articles in Studies in Political Economy, Canadian Medical Association Journal, and Journal of Medical Ethics, among others. She also directs the Politics of Reproduction Research Group at the University of Waterloo.

Alta Charo, J.D., is professor emerita of law and bioethics at the University of Wisconsin and an independent consultant to industry and government on biotechnology ethics, policy, and regulation. She was a

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

policy analyst for the congressional Office of Technology Assessment, the U.S. Agency for International Development, and FDA and a member of President Clinton’s National Bioethics Advisory Commission. She is a foreign member of the German Leopoldina and an elected member of AAAS, the American Academy of Arts and Sciences, and NAM, for which she cochaired its foundational reports on stem cell research and human genome editing.

Paula Cohen, Ph.D., is a professor of genetics, director at the Center for Reproductive Genomics, and associate vice provost for life sciences at Cornell University. Dr. Cohen obtained her Ph.D. in reproductive physiology in 1992 at the University of London, England, where she studied the endocrine regulation of implantation. In 1993, she took a postdoctoral position at the Albert Einstein College of Medicine, New York, where she focused on regulation of male and female gonadal function and maturation of the hypothalamic-pituitary-gonadal axis. During this time, she became interested in germ cell biology and genome integrity and transitioned into this area to study the roles of DNA repair proteins in mammalian meiosis. She joined the faculty of the Department of Genetics at Albert Einstein College in 2000; in 2004, she was recruited to Cornell’s Department of Biomedical Sciences. She was granted the rank of associate professor with indefinite tenure in 2007 and promoted to full professor in 2013. While at Cornell, she has received numerous merit awards for her research contributions, the Cornell Provost’s award for Distinguished Scholarship (2009), and the SUNY Chancellor’s award for Academic Excellence (2017). In January 2022, she was elected as an AAAS fellow.

Michele Goodwin, J.D., L.L.M., is a Chancellor’s Professor at the University of California, Irvine, and founding director of the Center for Biotechnology and Global Health Policy. She is the 2022 recipient of the American Bar Association’s Margaret Brent Award and the 2022 Trailblazer Award from the Black Women Lawyers Association of Los Angeles. In 2020–2021, she received the Distinguished Senior Faculty Award for Research, the highest honor bestowed by the University of California. She is also the first law professor at the University of California, Irvine to receive this award. In 2021–2022, she was named the Provost’s Distinguished Visiting Faculty Fellow at the University of Pennsylvania. She is an elected member of the American Law Institute and an elected fellow of the American Bar Foundation and the Hastings Center (the organization central to the founding of bioethics).

Anne Goriely, Ph.D., is a professor of human genetics and coheads the Clinical Genetics Laboratory at the MRC Weatherall Institute of Molecular

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

Medicine in Oxford. She obtained a Ph.D. studying the development of the nervous system of the Drosophila embryo, after an undergraduate degree in engineering (agronomy) at the Université Libre de Bruxelles (Belgium). She spent 4 years in New York at Cornell Medical School and Rockefeller University before moving to the United Kingdom to work on the nervous system development of the chick embryo. In 2000, she joined the MRC Weatherall Institute to study the origin of rare human developmental disorders. Using a human genetics approach, her group is mainly interested in elucidating the mechanisms by which we acquire new mutations and the implications of such processes in health, disease, and human evolution.

Tanika Gray Valbrun, B.S., is an award-winning journalist, educator, and nonprofit founder. After her struggles with uterine fibroids, including two myomectomies, her passion for women’s health inspired her to create the White Dress Project, a nonprofit dedicated to providing support for women suffering from fibroids and raising awareness for fibroid education; she has worked with doctors, health advocates, and elected officials across the country to successfully pass legislation declaring July as “Fibroids Awareness Month.” Recognized as a thought leader and patient advocate for uterine health, she has also spoken around the world encouraging women to be their own best health advocate. Many women with symptomatic fibroids never dream of wearing white, because of their heavy menstrual bleeding or bloating. The white dress is a “symbol of hope” that women with fibroids can feel supported and know that they do not have to suffer in silence. In addition to encouraging women to be their own health advocates, she works as a senior content producer for a global news organization, where she has been awarded three coveted Peabody Awards for her contributions in journalism.

Henry (Hank) Greely, J.D., is the Deane F. and Kate Edelman Johnson Professor of Law; professor, by courtesy, of genetics; and director of the Center for Law and the Biosciences at Stanford University. He specializes in ethical, legal, and social issues arising from biosciences, particularly genetics, neuroscience, stem cell research, and assisted reproduction. He is a founder and a past president of the International Neuroethics Society and chairs the California Advisory Committee on Human Stem Cell Research and the Ethical, Legal, and Social Issues Committee of the Earth BioGenome Project. For 6 years, until August 2022, he served on the NIH BRAIN Initiative’s Multi-Council Working Group while cochairing its Neuroethics Work Group. He is the author of The End of Sex and the Future of Human Reproduction (Harvard University Press, 2016) and CRISPR People: The Science and Ethics of Editing Humans (MIT Press, 2021). He graduated

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

from Stanford in 1974 and Yale Law School in 1977. He clerked for Judge John Minor Wisdom of the Fifth Circuit Court of Appeals and Justice Potter Stewart, then served in the Departments of Defense and Energy in the Carter Administration. He was a litigator at the Los Angeles firm Tuttle & Taylor before joining the Stanford faculty in 1985.

Petra Hajokova, Ph.D., is a professor of developmental epigenetics at Imperial College London, Institute of Clinical Sciences. She is also the chair of the Epigenetic Section at the MRC LMS. She earned her Ph.D. at the Max Planck Institute for Molecular Genetics in Berlin and her undergraduate degree at Charles University in Prague. Dr. Hajkova joined Azim Surani’s laboratory at the Gurdon Institute in Cambridge to investigate the process of epigenetic reprogramming in vivo, after which she established her own laboratory at the MRC LMS in 2009. Her group has been using genetic and biochemical approaches to understand the basis of epigenetic reprogramming and germ cell development, unraveling how epigenetic information is transmitted, erased, and reinstated during mammalian life cycles. She was appointed a young investigator for the European Molecular Biology Organisation (EMBO) in 2013, awarded the prestigious Mary Lyon medal by the Genetics Society in 2017, and selected as an EMBO member in 2018. She was elected to the Fellowship of the Academy of Medical Sciences in 2022.

Lorian Hardcastle, S.J.D., is an associate professor in the Faculty of Law at the University of Calgary, with a joint appointment to the Department of Community Health Sciences in the Cumming School of Medicine. She is also a member of the One Health Consortium, O’Brien Institute for Public Health, and Conjoint Health Research Ethics Board at the University of Calgary. She obtained her J.D. with Health Law and Policy Specialization Certificate from Dalhousie University and her L.L.M. and S.J.D. from the University of Toronto. She also completed a fellowship at the O’Neill Institute for National and Global Health Law at Georgetown University Law Center. Ms. Hardcastle is involved in research on antimicrobial resistance (funded by Alberta’s Major Innovation Fund), artificial intelligence and health (funded by CIHR), regulation of long-term care, and legal and policy issues arising from COVID-19. Her work has been published in numerous legal and health policy journals, including the Canadian Medical Association Journal, University of Pennsylvania Law Review, Healthcare Policy, Alberta Law Review, Queen’s Law Journal, and Journal of Law, Medicine & Ethics. Ms. Hardcastle is a frequent contributor to health policy debates in the media. Her writing has appeared in several Canadian newspapers, including Globe and Mail, Toronto Star, Calgary Herald, Edmonton Journal, and Ottawa Citizen.

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

Katsuhiko Hayashi, Ph.D., is a professor of stem cell biology and medicine at the National University Corporation Kyushu University. His research focuses on understanding molecular mechanisms underlying primordial germ cell specification and functional interaction between germ cells and gonadal somatic cells and reconstituting germ cell development in vitro. He is a member of the Japanese Society of Developmental Biologists, Molecular Biology Society of Japan, and Society of Reproduction and Development.

Lisa Ikemoto, J.D., L.L.M., is the Martin Luther King, Jr., Professor of Law at UC Davis School of Law. Her research areas include science, technology and the law, bioethics, reproductive rights and justice, and health care disparities. She focuses on how race, gender, disability, and wealth mediate access to and impacts of biomedical technology use and health care. Her recent work addresses reprogenetic technology markets, reproductive justice, the role of provider religious exemptions in health care inequality, eugenics, and fertility tourism. She teaches Bioethics, Reproductive Rights & Justice, and Health Care Law. She has faculty affiliations with the Aoki Center for Race and Nation Studies, Center for Health Policy Research, Feminist Research Institute, and Religious Studies Department.

Jeffrey Kahn, Ph.D., M.P.H., is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics and Levi Professor of Bioethics and Public Policy. He is also a professor in the Department of Health Policy and Management in the Johns Hopkins University Bloomberg School of Public Health. His research interests include the ethics of research, ethics and public health, and ethics and emerging biomedical technologies. He speaks widely both in the United States and abroad, has published six books and more than 140 articles, and is co-PI for the Oxford–Johns Hopkins Global Infectious Disease Ethics Collaborative (Wellcome Trust). He is an elected member of NAM and fellow of the Hastings Center (U.S.) and has chaired or served on committees and panels for NIH, Centers for Disease Control (U.S.), NAM, Wellcome Trust (UK), and Royal Society (UK). His education includes a B.A. in microbiology (UCLA, 1983), M.P.H. (Johns Hopkins, 1988), and Ph.D. in philosophy (Georgetown, 1989).

Katherine Kraschel, J.D., is a lecturer in law and the outgoing executive director of the Solomon Center for Health Law and Policy at Yale Law School, where she coteaches the Reproductive Rights and Justice Project Clinic. In July 2023, she will join the faculty at Northeastern University as an assistant professor of law and health sciences. Her scholarship focuses on the intersection of reproduction, gender, bioethics, and health policy with a particular concentration on reproductive technologies. Her work has appeared in prominent journals, including Journal of the American Medical

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

Association, Harvard Journal of Law and Gender, American Journal of Obstetrics and Gynecology, and Journal of Law, Medicine and Ethics. She is a member of the board of directors and officer of Planned Parenthood of Southern New England. She was associate counsel at Yale New Haven Health. She holds a B.A. in biochemistry from Mount Holyoke College and a law degree from Harvard Law School. In 2016, the National LGBT Bar Association named her one of the Best LGBT Lawyers Under 40, and in 2018, she was named one of the top 40 Lawyers under 40 by the American Bar Association.

Matt Krisiloff is CEO and cofounder of Conception Biosciences, a research company working on developing a protocol to turn human induced pluripotent stem cells (iPSCs) into mature egg cells. It is based in Berkeley, California, and has close to 40 full-time scientists working on this goal. He is also a partner and cofounder of SciFounders, was director of Y Combinator Research, and was a founding team member of OpenAI. He received his degree from the University of Chicago.

Hannah Landecker, Ph.D., B.Sc., is a professor in the Sociology Department at UCLA. She is a historian and sociologist of the life sciences. She holds a joint appointment in UCLA’s Life and Social Sciences and the Institute for Society and Genetics, an interdisciplinary unit committed to cultivating research and pedagogy at the interface of the life and human sciences. She is the author of Culturing Life: How Cells Became Technologies (Harvard University Press, 2007) and has written widely on biotechnology and society in work funded by NIH, the National Science Foundation, the American Council of Learned Societies, and the National Endowment for the Humanities. She is codirector of the Center for Reproductive Science, Health, and Education at UCLA and senior editor of the social science journal BioSocieties. At this workshop, she represented a team of researchers working to understand views and questions about IVG among members of the interested public, including the LGBTQ community and groups impacted by infertility.

Peter Marks, Ph.D., M.D., is the director of the Center for Biologics Evaluation and Research (CBER) for FDA (as of 2016). The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies. Dr. Marks and center staff are committed to facilitating the development of biological products and providing oversight throughout the product life cycle, including reviewing and providing advice during product development, evaluating applications and making approval decisions based on safety and effectiveness data, monitoring the safety of biological products, and conducting research

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

that supports product development and characterization. Dr. Marks received his graduate degree in cell and molecular biology and his M.D. at New York University; he completed an internal medicine residency and hematology/medical oncology fellowship at Brigham and Women’s Hospital in Boston, where he joined the attending staff as a clinician-scientist and became clinical director of hematology. He joined FDA in 2012 as deputy center director for CBER. Dr. Marks is board certified in internal medicine, hematology, and medical oncology and a fellow of the American College of Physicians. In 2022, he became a member of NAM.

Erica Marsh, M.D., M.Sci., FACOG, is the University Diversity and Social Transformation Professor and the S. Jan Behrman Collegiate Professor of Reproductive Medicine in the Department of Obstetrics and Gynecology at the University of Michigan Medical School and chief of the Division of Reproductive Endocrinology and Infertility in the Department of OBGYN. She also serves as the associate director of the Michigan Institute of Clinical and Health Research and the founder and director of Health and Reproductive Disparities Collaborative. Dr. Marsh attended Harvard College, graduating magna cum laude, and Harvard Medical School, graduating cum laude. She undertook the integrated OBGYN residency at Brigham and Women’s Hospital and Massachusetts General Hospital, followed by a reproductive endocrinology and infertility fellowship at the Feinberg School of Medicine at Northwestern University. Next, she joined the faculty at Feinberg. In 2016, she joined the University of Michigan. Dr. Marsh has received millions of dollars in funding to support her research, which focuses on health disparities in reproductive medicine; she takes a 360° approach, with a focus on leveraging the strengths and expertise of community and community engagement to investigate research questions. She has published significantly in the areas of fibroids, abnormal uterine bleeding, infertility, and COVD-19. Her work is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute on Minority Health and Health Disparities, and the Chan Zuckerberg Foundation.

Kyle Orwig, Ph.D., is a professor of obstetrics, gynecology, and reproductive sciences at the University of Pittsburgh School of Medicine. He is also the director of the Fertility Preservation Program and the Center for Reproduction and Transplantation at Magee-Women’s Hospital of the University of Pittsburgh. Research in the Orwig laboratory focuses on stem cells, germ lineage development, fertility, and infertility. Its progress investigating reproductive function in fertile individuals provides a basis for understanding the mechanisms of infertility caused by disease, medical treatments, genetic defects, or aging. Infertility impacts one in

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

seven U.S. couples and can have a devastating impact on relationships, emotional well-being, and overall health. The laboratory is located in Magee-Women’s Research Institute and Magee-Women’s Hospital and committed to translating bench discoveries to the clinic to diagnose, prevent, and treat infertility.

Amrita Pande, Ph.D., is a professor in sociology at University of Cape Town, South Africa. Her research focuses on the intersection of globalization and the intimate. Her work has appeared in many international journals and numerous edited volumes. Her most recent books include Birth Controlled: Selective Reproduction and Neo Eugenics in India and South Africa (Manchester University Press, 2022) and Wombs in Labor: Transnational Surrogacy in India (Columbia University Press and Primus Press, 2019). Over the past two decades, she has conducted multisited research on fertility clinics, traveling egg provision, and cross-border surrogacy in India, Cambodia, Ghana, and South Africa. She is also an educator-performer, touring the world with a performance lecture series, Made in India (Global Studies Production, Denmark), based on her ethnographic work on surrogacy.

Joel Michael Reynolds, Ph.D., M.A., is an assistant professor of philosophy and disability studies at Georgetown University, senior research scholar in the Kennedy Institute of Ethics, senior bioethics advisor to and fellow of the Hastings Center, and faculty scholar of the Greenwall Foundation. They are the author or coauthor of over 50 journal articles, book chapters, and scholarly commentaries and five books: The Life Worth Living: Disability, Pain, and Morality (University of Minnesota Press, 2022), The Disability Bioethics Reader (Routledge, 2022), The Art of Flourishing: Conversations on Disability, Technology, and Belonging (Oxford University Press, 2024), The Meaning of Disability (Oxford University Press, 2024), and Philosophy of Disability: An Introduction (Polity, 2024). Their article-length work appears in leading journals across multiple fields, including The New England Journal of Medicine, Nature Biotechnology, Episteme, Biological Psychiatry, and Journal of Medical Ethics. They are the founder of The Journal of Philosophy of Disability and cofounder of Oxford Studies in Disability, Ethics, and Society from Oxford University Press, both of which they coedit. Their public scholarship includes pieces in Time, AEON, The Conversation, Health Progress, The Bioethics Forum, The Philosopher, and a TEDx talk.

Mitinori Saitou, Ph.D., M.D., is a professor in the Department of Life Sciences Frontiers at Kyoto University and the director for the Institute for the Advanced Study of Human Biology. Dr. Saitou earned his M.D. and Ph.D. from Kyoto University. His research focuses on understanding the

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×

mechanisms that regulate germ development, particularly reconstituting this process in vitro.

Gamal Serour, M.D., is professor of obstetrics and gynecology and director of the International Islamic Center for Population Studies and Research at Al Azhar University in Cairo. He is the former dean of faculty of medicine at Al Zohar University. Dr. Serour is the past president of the international federation of obstetrics and gynecology and former chair of its bioethics committee. He is also a past member of the Intergovernmental Bioethics Committee and International Bioethics Committee of UNESCO. He is the cochair of the World Health Organization (WHO) Regional Office for the Eastern Mediterranean (EMRO) health research ethics committee. He is the former member and chair of the WHO Scientific and Technical Advisory Groups for the Special Programme of Research, Development and Research Training in Human Reproduction (HRP) in the Department of Reproductive Health and Research. He is a member of the Islamic Research Council, Al Azhar. He is also the president of the board of directors of the IVF Center, Maadi, Cairo, Egyptian Fertility and Sterility Society, and African Federation of Fertility Societies.

Azim Surani, Ph.D., CBE, FRS, FMedSci, is the director of germline and epigenetics research at the Gurdon Institute at the University of Cambridge as of 2013. He received his Ph.D. at Cambridge in 1975 and was elected as Marshall-Walton Professor in 1992. He is a Fellow of the Royal Society and the Academy of Sciences. His awards include the William Bate Hardy Prize, Royal Medal for mammalian development, Rosenstiel Award for epigenetic regulation of gene expression in mammalian embryos, ISSCR McEwen Award for Innovation, and Canada Gairdner International Award for genomic imprinting and epigenetics.

Sonia Suter, J.D., M.S., is the Kahan Family Research Professor of Law, the Henry St. George Tucker III Dean’s Research Professor of Law, and founding director of the Health Law Initiative at George Washington University Law School. A former genetic counselor, she has published widely in law reviews, peer-reviewed interdisciplinary journals, and science journals. Her research addresses issues at the intersection of law, medicine, and bioethics, with a particular focus on reproductive rights and justice, emerging reproductive technologies, and ethical and legal issues in genetics. She is coauthor of two leading textbooks in these fields: Genetics: Ethics, Law and Policy and Reproductive Technologies and the Law. In addition, she participates in national working groups and advisory boards and as a consultant to policy makers on issues in her field of expertise. She earned an M.S. and Ph.D. candidacy in human genetics and a J.D. from the University of Michigan.

Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 133
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 134
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 135
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 136
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 137
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 138
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 139
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 140
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 141
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 142
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 143
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 144
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 145
Suggested Citation:"Appendix C: Biographies of Speakers and Planning Committee Members." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
×
Page 146
In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop Get This Book
×
 In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop
Buy Paperback | $23.00 Buy Ebook | $18.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Current assisted reproductive technologies such as in vitro fertilization (IVF) do not enable all prospective parents to have genetically related children. The National Academies Board on Health Sciences Policy hosted a workshop in April 2023 to explore the development of in vitro-derived human eggs and sperm from pluripotent stem cells through a process known as in vitro gametogenesis (IVG). Speakers emphasized the impacts of the potential biotechnology on research and reproductive medicine should clinical IVG ever be approved, along with the many social, ethical, legal, and technical considerations its development raises. This proceedings document summarizes workshop discussions.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!